AxoGen Revenue Chart

Add to My Stocks
$54.9 $0.75 (1.39%) AXGN stock closing price Jul 17, 2018 (Closing)
The latest 2018-Q1 AxoGen revenue is 17.26M. Compare AxoGen revenue chart with Supernus Pharma revenue, Akorn revenue.

AXGN Revenue Chart

Quarterly Annual
  • Download
    • Download PNG image
    • Download JPEG image
    • Download SVG image
    • Download PDF document
Compare with
AKRX revenue
MNK revenue
NVRO revenue
NVTR revenue
You can do annual as well as quarterly comparisons of AxoGen, Inc. net sales with its competitor companies like Supernus Pharma, Akorn. Over the 5 year period AxoGen revenue in 2017 was highest at 60.42M. In the latest quarter, AXGN revenue 2018-Q1 has changed from 16.97M to 17.26M implying an increase of 1.71%.

AxoGen Quarterly Revenue

* Past 5 years Range

Max AXGN Revenue $17.26M Mar, 2018
Min AXGN Revenue $2.86M Jun, 2013

AxoGen Annual Revenue

* Past 5 years Range

Max AXGN Revenue $60.42M Dec, 2017
Min AXGN Revenue $10.94M Dec, 2013

AxoGen Annual Revenue VS Peers

2017 2016 2015 2014 2013
AxoGen Revenue $60.42M$41.1M$27.33M$16.81M$10.94M
Supernus Pharma Revenue $302.23M$215M$144.42M$122.04M$12.01M
Akorn Revenue $841.04M$1.12B$985.07M$593.07M$317.71M
Mallinckrodt Revenue $3.22B$829.9M$914.8M$866.3M$540.2M
Nuvectra Revenue $31.83M$12.53M$5.23M$3.69M----
Nevro Revenue $326.67M$228.5M$69.6M$32.57M$23.5M
Revenue, Sales, Turnover or net sales basically describes the Dollar value of transactions that result in incomes to a business as a result of business or operating activities during a specific period of time. Most often, this number is reported on a quarterly or annual basis. Since this features right at the top of an income statement, or profit and loss statement, also known as the statement of operations, the line item is also known as the ‘top line’ for a company. Other commonly used phrases include gross income and income from operations under IFRS. When you deduct expenses, costs and overheads, you arrive at the profit figure. For instance, when you net off AxoGen revenue with AxoGen expenses, the figure that you arrive at will be AxoGen profit. This profit is also known as the bottom line due to its proximity to the bottom on the income statement. Growing top line numbers are a sign of financial health. That said, sales cannot be viewed on a standalone basis without considering profits, because ultimately, businesses are run with the aim of making profits after covering costs. Revenue can be calculated in two ways based on the type of accounting followed: accrual accounting or cashflow accounting. It’s a good exercise to to compare AxoGen revenue with that of its peers. For instance, you can compare Skyepharma topline, with Versartis topline, Invivo Therapeautics topline, etc to assess how the company is doing with respect to its peers.